CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Association Between Functional Impairment and Medication Burden in Adults with Heart Failure Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction The Role of the Pericardium in Heart Failure: Implications for Pathophysiology and Treatment Mechanical circulatory support devices for acute right ventricular failure Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF) Association of Cardiovascular Disease With Respiratory Disease Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

Original Research2020 Jul 18.

JOURNAL:ESC Heart Fail. Article Link

Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT-HF study

JA Borovac, D Glavas, ZS Grabovac et al. Keywords: acute decompensated heart failure; catestatin; HF; hospital mortality; risk stratification; soluble suppression of tumourigenicity

Full Text PDF